Microthrombi and ST-Segment-Elevation Myocardial Infarction in COVID-19

Circulation. 2020 Aug 25;142(8):804-809. doi: 10.1161/CIRCULATIONAHA.120.049294. Epub 2020 Jul 17.

Authors

Giulio Guagliumi¹, Aurelio Sonzogni², Irene Pescetelli¹, Dario Pellegrini¹, Aloke V Finn³

Affiliations

¹ Interventional Cardiology, Cardiovascular Department(G.G., I.P., D.P.), Ospedale Papa Giovanni XXIII Bergamo, Italy.
² Pathology Unit(A.S.), Ospedale Papa Giovanni XXIII Bergamo, Italy.
³ University of Maryland, Baltimore(A.V.F.).

Abstract

Supplemental Digital Content is available in the text.

Keywords: COVID-19; ST elevation myocardial infarction; thrombosis.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antiviral Agents / therapeutic use
Betacoronavirus / isolation & purification
C-Reactive Protein / analysis
COVID-19
Cobicistat / therapeutic use
Coronavirus Infections / complications
Coronavirus Infections / diagnosis*
Coronavirus Infections / drug therapy
Coronavirus Infections / virology
Darunavir / therapeutic use
Electrocardiography
Female
Humans
Hypokinesia / diagnosis
Hypokinesia / etiology
Hypotension / complications
Hypotension / pathology
International Normalized Ratio
Myocardium / pathology
Nasopharynx / virology
Pandemics
Platelet Count
Pneumonia, Viral / complications
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / drug therapy
Pneumonia, Viral / virology
SARS-CoV-2
ST Elevation Myocardial Infarction / complications
ST Elevation Myocardial Infarction / diagnosis*
Thrombosis / complications
Thrombosis / diagnosis*
Troponin I / analysis
Ventricular Dysfunction, Left / complications
Ventricular Dysfunction, Left / diagnosis

Substances

Antiviral Agents
Troponin I
C-Reactive Protein
Cobicistat
Darunavir